Find policies, billing codes, payers, states, and providers
Loading...
Find policies, billing codes, payers, states, and providers
CPT 52204: Cystourethroscopy with Biopsy
CPT-52214-TRANSURETHRAL-BLADDER-URETHRAL-TISSUE-DESTRUCTIONCPT 52214: Endoscopic Destruction of Bladder/Urethral Tissue
CPT-52224-CYSTOSCOPY-LESION-DESTRUCTION-MINORCPT 52224: Cystoscopy with Destruction of Minor Bladder Lesion
CPT-52234-CYSTOSCOPIC-DESTRUCTION-SMALL-BLADDER-LESIONCPT 52234: Cystoscopy with Destruction of Small Bladder Lesion
CPT-52235-CYSTOSCOPIC-DESTRUCTION-MEDIUM-BLADDER-LESION-2-5CMCPT 52235: Cystoscopy with Fulguration of Medium Bladder Lesion
CPT-52240-CYSTOSCOPY-LESION-FULGURATION-ABLATION-GREATER-THAN-5CMCPT 52240: Cystoscopy with Destruction of Bladder Lesion (>5.0 cm)
CPT-52250-CYSTOSCOPIC-INTRAVESICAL-RADIOACTIVE-THERAPY-FOR-BLADDER-CANCERCPT 52250: Cystoscopy with Intravesical Radioisotope Therapy
CPT-52260-DIAGNOSTIC-CYSTOSCOPY-INTERSTITIAL-CYSTITIS-EVALUATIONCPT 52260: Cystoscopic Inspection Under Anesthesia for Interstitial Cystitis
CPT-52265-DIAGNOSTIC-CYSTOSCOPY-INTERSTITIAL-CYSTITIS-EVALUATIONCPT 52265: Diagnostic Cystoscopy for Interstitial Cystitis
CPT-52270-CYSTOSCOPIC-URETHROTOMY-INTERNAL-URETHRAL-STRICTURECPT 52270: Cystoscopy with Incision of Internal Urethral Stricture (Female)
Showing 1–10 of 27
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.